Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>Delirium is the most common postoperative neurological complication and some evidence suggests that dexmedetomidine is associated with a decreased incidence of delirium. This study is designed to assess the effect of dexmedetomidine on postoperative delirium (POD) in elderly patients with mild cognitive impairment (MCI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Sixty geriatric patients with MCI were enrolled and ramdomly divided into two groups by a computer‐generated randomisation sequence: dexmedetomidine group (D group) and normal saline group (C group). Patients in D group received a loading dose of 0.5 μg/kg dexmedetomidine over 10 minutes before anesthesia induction, followed by a continuous infusion of 0.4 μg·kg<sup>‐1</sup>·h<sup>‐1</sup> until 30 min before the end of surgery; equal volume of normal saline was given in C group. Blood samples were extracted to detect the concentration of cytokines, including TNF‐α, IL‐10, HO‐1, matrix metalloproteinase‐9 (MMP‐9) and glial fibrillary acidic protein (GFAP) before anesthesia induction (T<sub>1</sub>), before suture (T<sub>2</sub>), and 30 min after surgery (T<sub>3</sub>). Postoperative recovery times were recorded. Delirium was assessed with the 3‐Minute Diagnostic Interview for confusion assessment method during the first 7 days postoperatively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>POD occurred in 10 (33.3%) of 30 patients in C group, and in 3 (10%) of 30 patients given dexmedetomidine (odds ratio [OR] 0.222, 95% CI 0.054–0.914; <i>P</i>=0.028). The serum concentrations of TNF‐α, MMP‐9, and GFAP were significantly increased and IL‐10 was decreased in the C group than in the D group at T<sub>2</sub> and T<sub>3</sub>. No differences were observed between groups in the level of HO‐1. Analysis using random‐effect multivariable logistic regression indicated that POD was associated with GFAP (odds ratio [OR] 16.691, 95% CI 2.288–121.746; <i>P</i>=0.005). The positive predictive ability of the multivariate logistic regression model tested by ROC analysis showed an area under the curve of 0.713 (95% CI, 0.584–0.842). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Dexmedetomidine can alleviate POD in elderly patients with MCI and may be related to reduce the neuroinflammation by lowering the permeability of blood‐brain barrier.</p><p>This article is protected by copyright. All rights reserved.</p></section>

Dexmedetomidine Improves Postoperative Cognitive Dysfunction: Mechanism and Progress

Dexmedetomidine Might Improve Postoperative Cognitive Dysfunction in Older Patients Undergoing Pulmonary Surgery

Benefits of Dexmedetomidine in Improving Postoperative Recovery

Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis

Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction in Aged Mice

The Effect and Optimal Dosage of Dexmedetomidine Plus Sufentanil for Postoperative Analgesia in Elderly Patients With Postoperative Delirium and Early Postoperative Cognitive Dysfunction: A Single-Center, Prospective, Randomized, Double-Blind, Controlled Trial

Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery

Dexmedetomidine for Postoperative Delirium Prevention in the Older Adult: An Integrative Review

Effects of dexmedetomidine on emergence delirium and electroencephalogram during the recovery period in older patients undergoing lower limb orthopedic surgery: A randomized, double-blind, placebo-controlled clinical trial

How useful is the detection kit for antibody to Helicobacter pylori in urine (URINELISA) in clinical practice?

Role of Dexmedetomidine in Early POCD in Patients Undergoing Thoracic Surgery

Dexmedetomidine Effect on Delirium in Elderly Patients Undergoing General Anesthesia: A Protocol for Systematic Review and Meta-Analysis.

Dexmedetomidine ameliorates postoperative cognitive dysfunction by inhibiting Toll‐like receptor 4 signaling in aged mice

Effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients undergoing orthopaedic surgery: study protocol for a randomized controlled trial

Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment

Dexmedetomidine effect on delirium in elderly patients undergoing general anesthesia

The role of dexmedetomidine administered via intravenous infusion as adjunctive therapy to mitigate postoperative delirium and postoperative cognitive dysfunction in elderly patients undergoing regional anesthesia: a meta-analysis of randomized controlled trials

Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials

Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases

Effect of Dexmedetomidine with Different Anesthetic Dosage on Neurocognitive Function in Elderly Patients After Operation Based on Neural Network Model

Effects of Dexmedetomidine on Cardioprotection and Other Postoperative Complications in Elderly Patients after Cardiac and Non-Cardiac Surgerie